Literature DB >> 25265979

Diabetes: MSC transplant prevents β-cell dysfunction.

David Holmes.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25265979     DOI： 10.1038/nrendo.2014.172

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.

Authors:  Per-Ola Carlsson; Erik Schwarcz; Olle Korsgren; Katarina Le Blanc
Journal:  Diabetes       Date:  2014-09-09       Impact factor: 9.461
  1 in total
  3 in total

1.  Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics.

Authors:  Le Wang; Leisheng Zhang; Xue Liang; Jiaqi Zou; Na Liu; Tengli Liu; Guanqiao Wang; Xuejie Ding; Yaojuan Liu; Boya Zhang; Rui Liang; Shusen Wang
Journal:  Int J Stem Cells       Date:  2020-07-30       Impact factor: 2.500

Review 2.  Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.

Authors:  Joana R Ferreira; Graciosa Q Teixeira; Susana G Santos; Mário A Barbosa; Graça Almeida-Porada; Raquel M Gonçalves
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

3.  Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease.

Authors:  Qinjun Zhao; Leisheng Zhang; Yimeng Wei; Hao Yu; Linglin Zou; Jiali Huo; Hongju Yang; Baoquan Song; Teng Wei; Dan Wu; Wenxia Zhang; Lei Zhang; Dengke Liu; Zongjin Li; Ying Chi; Zhibo Han; Zhongchao Han
Journal:  Stem Cell Res Ther       Date:  2019-11-28       Impact factor: 6.832
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.